NextPlat Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
1analyst covering
FY Revenue (est.)
$49.7Mnext fiscal year
FY EPS (est.)
-$0.85next fiscal year
Monitoring Framework
Key Performance Indicators
Consolidated Revenue Quarterly9.9MTarget: Expected positive operating income in the latter half of 2026
Consolidated Gross Margin Quarterly35.0%Target: Maintain elevated margins throughout 2026
Healthcare Operations Pharmacy Contract Revenue Quarterly1.9MTarget: Expand geographic reach beyond Florida via HealthWarehouse partnership
Watch Items
- Supply Overhang from Resale RegistrationTrigger: Resale of up to 2,097,011 shares by selling securityholdersAction: Monitor daily trading volume and Form 4 filings to assess market absorption and potential downward pressure on the stock price.
- Nasdaq Minimum Bid Price ComplianceTrigger: Stock price falling below $1.00 for consecutive trading daysAction: Evaluate the long-term impact of the 1-for-10 reverse stock split executed on April 13, 2026, and monitor bid price stability.
Research as of 20 Jun 2026